Home
About
Overview
Sharing Data
ORCID
Help
History (76)
Neuropsychological assessments and psychotherapeutic services in Veterans with multiple sclerosis: Rates of utilization and their associations with socio-demographics and clinical characteristics using Veterans Health Administration-based data.
Phase I dose-escalation study to examine the safety and tolerability of LY2603618, a checkpoint 1 kinase inhibitor, administered 1 day after pemetrexed 500?mg/m(2) every 21 days in patients with cancer.
Compensation and Pension Exams for Military Sexual Trauma-Related Posttraumatic Stress Disorder: Examiner Perspectives, Clinical Impacts on Veterans, and Strategies.
Biological Basis for Amyloidogenesis in Alzheimer's Disease.
Immunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II.
See All 76 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II.
Aliseychik MP, Andreeva TV, Rogaev EI. Immunogenetic Factors of Neurodegenerative Diseases: The Role of HLA Class II. Biochemistry (Mosc). 2018 Sep; 83(9):1104-1116.
View in:
PubMed
subject areas
Adaptive Immunity
Alzheimer Disease
Histocompatibility Antigens Class II
HLA-DR alpha-Chains
HLA-DRB1 Chains
Humans
Neurodegenerative Diseases
Parkinson Disease
Polymorphism, Single Nucleotide
Presenilins
authors with profiles
Evgeny I Rogaev PhD